Cellulose Acetate 1,2-Benzenedicarboxylate Inhibits Infection by Cell-Free and Cell-Associated Primary HIV-1 Isolates
- 1 May 2006
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 22 (5) , 411-418
Abstract
Cellulose acetate 1,2-benzenedicarboxylate (CAP), a pharmaceutical excipient used for enteric film coating of capsules and tablets, was previously shown to have potent inhibitory activity against infection by human immunodeficiency virus type 1 (HIV-1) T cell line-adapted (TCLA) strains. In the present study, we determined the inhibitory activity of CAP against infection by cell-free and cell-associated primary HIV-1 isolates with distinct genotypes and biotypes in cervical explants, peripheral blood mononuclear cells (PBMCs), monocytederived macrophages (MDMs), and CEMx174 5.25M7 cells. CAP blocked infection by cell-free and cell-associated HIV-1 in cervical explants. It inhibited infection by cell-free primary HIV-1 isolates (clades A to G and group O) in PBMCs, MDMs, and CEMx174 5.25M7 cells and blocked transmissions of the cell-associated primary HIV-1 isolates from dendritic cells (DCs) to PBMCs, from MDMs to PBMCs, and from PBMCs to CEMx174 5.25M7 cells. The inhibitory activity of CAP on infection by the cell-free and cell-associated primary HIV-1 isolates is independent of viral subtypes and coreceptor usage. These data suggest that CAP is a good microbicide candidate that can be further developed for preventing sexual transmission of HIV-1.Keywords
This publication has 35 references indexed in Scilit:
- Combination of Candidate Microbicides Cellulose Acetate 1,2-Benzenedicarboxylate and UC781 Has Synergistic and Complementary Effects against Human Immunodeficiency Virus Type 1 InfectionAntimicrobial Agents and Chemotherapy, 2005
- Multiple Vaginal Exposures to Low Doses of R5 Simian‐Human Immunodeficiency Virus: Strategy to Study HIV Preclinical Interventions in Nonhuman PrimatesThe Journal of Infectious Diseases, 2005
- Anti-Human Immunodeficiency Virus Type 1 Microbicide Cellulose Acetate 1,2-Benzenedicarboxylate in a Human In Vitro Model of Vaginal InflammationAntimicrobial Agents and Chemotherapy, 2005
- In Vitro Comparison of Topical Microbicides for Prevention of Human Immunodeficiency Virus Type 1 TransmissionAntimicrobial Agents and Chemotherapy, 2004
- Estrogen Protects against Vaginal Transmission of Simian Immunodeficiency VirusThe Journal of Infectious Diseases, 2000
- Design of a “Microbicide” for Prevention of Sexually Transmitted Diseases Using “Inactive” Pharmaceutical ExcipientsBiologicals, 1999
- Detection and biologic characterization of infectious HIV-1 in semen of seropositive menAIDS, 1994
- Slowing the Spread of HIV: Agenda for the 1990sScience, 1993
- Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types.Journal of Experimental Medicine, 1989
- soluble form of CD4 (T4) protein inhibits AIDS virus infectionNature, 1988